Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
23.93
-0.22 (-0.91%)
Nov 4, 2024, 4:00 PM EST - Market closed
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.29 billion as of November 4, 2024. Its market cap has increased by 68.48% in one year.
Market Cap
1.29B
Enterprise Value
924.43M
1-Year Change
68.48%
Ranking
Category
Stock Price
$23.93
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.29B, an increase of 102.95%. That is a compound annual growth rate of 20.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 1.30B | 13.46% |
| Dec 29, 2023 | 1.15B | 202.45% |
| Dec 30, 2022 | 380.10M | -20.26% |
| Dec 31, 2021 | 476.70M | -25.14% |
| Feb 5, 2021 | 636.80M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Progyny | 1.35B |
| Schrödinger | 1.31B |
| Enliven Therapeutics | 1.31B |
| Kura Oncology | 1.29B |
| Pediatrix Medical Group | 1.29B |
| Cogent Biosciences | 1.28B |
| Establishment Labs Holdings | 1.27B |
| Vir Biotechnology | 1.27B |